Pathological roles of purinergic signaling in the liver

Slides:



Advertisements
Similar presentations
EASL Clinical Practice Guidelines: Vascular diseases of the liver Journal of Hepatology Volume 64, Issue 1, Pages (January 2016) DOI: /j.jhep
Advertisements

Depression, anemia and health-related quality of life in chronic hepatitis C Amy A. Dan, Lisa M. Martin, Cathy Crone, Janus P. Ong, Denise W. Farmer, Thomas.
Omega 3 – Omega 6: What is right for the liver? Ashraf Mohammad El-Badry, Rolf Graf, Pierre-Alain Clavien Journal of Hepatology Volume 47, Issue 5, Pages.
Volume 63, Issue 1, Pages (July 2015)
Volume 53, Issue 1, Pages (July 2010)
Volume 46, Issue 3, Pages (March 2007)
The impact of hepatitis E in the liver transplant setting
Inflammasomes in liver diseases
Volume 50, Issue 4, Pages (April 2009)
Lifestyle interventions for the treatment of non-alcoholic fatty liver disease in adults: A systematic review  Christian Thoma, Christopher P. Day, Michael.
Tiny RNA with great effects: miR-155 in alcoholic liver disease
m-TOR inhibitors: What role in liver transplantation?
Hepatic CD141+IFNλ+ DC subset: One against all?
m-TOR inhibitors: What role in liver transplantation?
Novel insights in the interplay between inflammation and metabolic diseases: A role for the pathogen sensing kinase PKR  Nicolas Marsollier, Pascal Ferré,
The impact of hepatitis E in the liver transplant setting
Reactive oxygen species in the normal and acutely injured liver
Obesity, inflammation, and liver cancer
Cédric Coulouarn, Bruno Clément  Journal of Hepatology 
Matthew T. Kitson, Stuart K. Roberts  Journal of Hepatology 
Immigration and viral hepatitis
Volume 66, Issue 1, Pages 1-4 (January 2017)
Ype P. de Jong, Charles M. Rice, Alexander Ploss  Journal of Hepatology 
Living donor liver transplantation: is the hype over?
Nicolas Moniaux, Jamila Faivre  Journal of Hepatology 
Is 9 more than 2 also in allergic airway inflammation?
Mesenchymal stromal cell therapy for liver diseases
Reply to: “DCD consensus and futility in liver transplantation”
The place of downstaging for hepatocellular carcinoma
Hepatitis C core protein – The “core” of immune deception?
Signalling pathways in alcohol-induced liver inflammation
Volume 61, Issue 1, Pages S108-S119 (November 2014)
Burcin Ekser, Eric Lagasse  Journal of Hepatology 
Volume 70, Issue 1, Pages (January 2019)
Volume 45, Issue 4, Pages (October 2006)
Volume 62, Issue 3, Pages (March 2015)
Darius Moradpour, Arash Grakoui, Michael P. Manns 
Volume 59, Issue 3, Pages (September 2013)
EASL Clinical Practice Guidelines: Wilson’s disease
Roberto de Franchis, Aleksander Krag  Journal of Hepatology 
Volume 86, Issue 4, Pages (October 2014)
Cannabinoid signaling and liver therapeutics
Volume 50, Issue 4, Pages (April 2009)
Cédric Coulouarn, Bruno Clément  Journal of Hepatology 
Antiviral therapy for chronic hepatitis B: Challenges in Hong Kong
Volume 61, Issue 1, Pages S79-S90 (November 2014)
Immigration and viral hepatitis
The potential of induced pluripotent stem cell derived hepatocytes
Clinical Practice Guidelines of the European Association for the study of the Liver – Advancing methodology but preserving practicability  Markus Cornberg,
HCV targeting of patients with cirrhosis
The impact of intestinal microflora on serum bilirubin levels
Volume 63, Issue 1, Pages (July 2015)
The use of hemospray in portal hypertensive bleeding; a case series
Volume 62, Issue 3, Pages (March 2015)
m-TOR inhibitors: What role in liver transplantation?
Vincenzo Mazzaferro, Andrea Pulvirenti, Jorgelina Coppa 
Volume 65, Issue 4, Pages (October 2016)
Statins: Old drugs as new therapy for liver diseases?
Liver transplantation in children
Ana Lleo, M. Eric Gershwin, Alberto Mantovani, Pietro Invernizzi 
Reply to: “Flow cytometry makes all the difference”
Pathogenesis of cholestatic hepatitis C
The balance between Notch/Wnt signaling regulates progenitor cells’ commitment during liver repair: Mystery solved?  Mario Strazzabosco, Luca Fabris 
Inflammatory pathways in alcoholic steatohepatitis
Chimeric mouse model of hepatitis B virus infection
The relationship between age and fat infiltration in liver and muscle
Volume 58, Issue 4, Pages (April 2013)
Genetics of hepatocellular carcinoma: The next generation
Platelets arrive at the scene of fibrosis……studies
Thierry Gustot, Rajiv Jalan  Journal of Hepatology 
Presentation transcript:

Pathological roles of purinergic signaling in the liver Byron P. Vaughn, Simon C. Robson, Geoffrey Burnstock  Journal of Hepatology  Volume 57, Issue 4, Pages 916-920 (October 2012) DOI: 10.1016/j.jhep.2012.06.008 Copyright © 2012 European Association for the Study of the Liver Terms and Conditions

Fig. 1 An overview of the complex interplay between extracellular ATP and adenosine. As illustrated, purinergic signaling influences both the process of inflammation as well as cellular regeneration. Extracellular ATP from biologic stress can incite inflammation. As ATP is metabolized by ectonucleotidases on endothelial surfaces to adenosine, the inflammatory response is regulated through induction of immune suppressive T regulatory cells. This has important implications for potential therapies in malignancy and liver transplantation. Journal of Hepatology 2012 57, 916-920DOI: (10.1016/j.jhep.2012.06.008) Copyright © 2012 European Association for the Study of the Liver Terms and Conditions